Brian Mueller - 15 Mar 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
15 Mar 2023
Transactions value $
-$608,718
Form type
4
Filing time
17 Mar 2023, 21:42:21 UTC
Previous filing
02 Mar 2023
Next filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +9.63K +18.3% $0.00 62.3K 15 Mar 2023 Direct F1
transaction BMRN Common Stock Tax liability -$238K -2.71K -4.35% $87.74 59.6K 15 Mar 2023 Direct
transaction BMRN Common Stock Tax liability -$371K -3.97K -6.67% $93.41 55.6K 16 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +22K $0.00 22K 15 Mar 2023 Common Stock 22K $87.74 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2023. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.